Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...

Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...

Hims & Hers Health, Inc.'s subscriber growth, Novo Nordisk partnership, and FDA pill approval could boost financials. Click ...

Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...

Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved ... In contrast, Pfizer announced it would stop developing danuglipron, an oral GLP-1 pill, after a ...

Ozempic may improve fertility if you have PCOS. In a 2023 study, 27 women with obesity and PCOS took a weekly 0.5-milligram ...

Commenting on the news, Leerink said that the once-daily oral GLP-1 pill showed similar efficacy and safety relative to weekly injectable semaglutide ... molecule glucagon-like peptide-1 receptor ...

If approved, the pill formulation would be the first oral ... which studied a 25 mg dose of oral semaglutide in adults without diabetes but with obesity or at least one comorbidity.